156 related articles for article (PubMed ID: 6219754)
1. Role of Corynebacterium parvum in the activation of peritoneal macrophages. II. Identification of distinguishable anti-tumor activities by macrophage subpopulations.
Chapes SK; Haskill S
Cell Immunol; 1983 Feb; 76(1):49-57. PubMed ID: 6219754
[TBL] [Abstract][Full Text] [Related]
2. Evidence for granulocyte-mediated macrophage activation after C. parvum immunization.
Chapes SK; Haskill S
Cell Immunol; 1983 Feb; 75(2):367-77. PubMed ID: 6831566
[TBL] [Abstract][Full Text] [Related]
3. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.
Lee KC; Berry D
J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353
[TBL] [Abstract][Full Text] [Related]
4. Effects of different fractions of Corynebacterium parvum on the cytotoxic T-cell response to alloantigens in mice.
Lichtenstein A; Tuttle R; Cantrell J; Zighelboim J
J Natl Cancer Inst; 1982 Aug; 69(2):495-501. PubMed ID: 6213807
[TBL] [Abstract][Full Text] [Related]
5. Corynebacterium parvum stimulation of adherent and non-adherent cytotoxic cells in mice.
Hassan ZM; Rees RC; Potter CW
Br J Cancer; 1981 Oct; 44(4):532-8. PubMed ID: 7295509
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect between neutrophils and Corynebacterium parvum in the process of macrophage activation.
Chapes SK; Haskill S
Cancer Res; 1984 Jan; 44(1):31-4. PubMed ID: 6228293
[TBL] [Abstract][Full Text] [Related]
7. Rejection of murine ovarian cancer following treatment with regional immunotherapy: correlations with a neutrophil-mediated activation of cytostatic macrophages.
Lichtenstein A
Cell Immunol; 1985 Sep; 94(2):521-35. PubMed ID: 4028167
[TBL] [Abstract][Full Text] [Related]
8. Macrophage heterogeneity in tumor resistance: cytostatic and cytotoxic activity of Corynebacterium parvum-activated and proteose peptone-elicited rat macrophages against Moloney sarcoma tumor cells.
Campbell MW; Sholley MM; Miller GA
Cell Immunol; 1980 Mar; 50(1):153-68. PubMed ID: 7397781
[No Abstract] [Full Text] [Related]
9. [Equal sensitivity of normal or tumoral fibroblasts to cytotoxic and cytostatic effects of normal or "Corynebacterium parvum" activated peritoneal exudate cells (author's transl)].
Fray A; Lorinet AM; Thobie N; Halpern B
Ann Immunol (Paris); 1979; 130C(3):445-59. PubMed ID: 475346
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
[TBL] [Abstract][Full Text] [Related]
11. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.
Kiya K; Toge T; Harada K; Uozumi T; Hattori T
Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201
[TBL] [Abstract][Full Text] [Related]
12. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
13. Cytostatic activity of in vitro generated macrophages: evidence for a prostaglandin-independent reversible cytostatic mechanism.
Stout RD
Cell Immunol; 1985 Nov; 96(1):83-103. PubMed ID: 2424622
[TBL] [Abstract][Full Text] [Related]
14. Suppressor T cells and suppressor macrophages induced by Corynebacterium parvum.
Lichtenstein A; Murahata R; Sugasawara R; Zighelboim J
Cell Immunol; 1981 Mar; 58(2):257-68. PubMed ID: 6452218
[No Abstract] [Full Text] [Related]
15. Immunoregulation by macrophages II. Separation of mouse peritoneal macrophages having tumoricidal and bactericidal activities and those secreting PGE and interleukin I.
Hopper KE; Cahill JM
J Reticuloendothel Soc; 1983 Jun; 33(6):443-56. PubMed ID: 6602218
[TBL] [Abstract][Full Text] [Related]
16. Appearance of a cell surface antigen associated with the activation of peritoneal macrophages in mice.
Akagawa KS; Tokunaga T
Microbiol Immunol; 1982; 26(9):831-42. PubMed ID: 7154991
[TBL] [Abstract][Full Text] [Related]
17. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
[TBL] [Abstract][Full Text] [Related]
18. Activation and mechanism of action of suppressor macrophages.
Lichtenstein A; Murahata R; Terpenning M; Cantrell J; Zighelboim J
Cell Immunol; 1981 Oct; 64(1):150-61. PubMed ID: 6457695
[No Abstract] [Full Text] [Related]
19. Differential sensitivity of two murine leukaemia sublines to cytolysis by Corynebacterium parvum-activated macrophages.
Berd D; Mastrangelo MJ
Br J Cancer; 1981 Dec; 44(6):819-27. PubMed ID: 7326193
[TBL] [Abstract][Full Text] [Related]
20. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages.
Sugawara I; Lee KC; Wong M
Cancer Immunol Immunother; 1984; 16(3):137-44. PubMed ID: 6322974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
